PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1213.73%
Some net income increase while BTE is negative at -3.99%. John Neff would see a short-term edge over the struggling competitor.
6.11%
D&A growth well above BTE's 0.96%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
292.46%
Some yoy growth while BTE is negative at -316.34%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-41.66%
Both reduce yoy usage, with BTE at -222.05%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-41.66%
Both reduce yoy usage, with BTE at -222.05%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-72.45%
Negative yoy while BTE is 189.35%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
13.66%
Some CFO growth while BTE is negative at -16.43%. John Neff would note a short-term liquidity lead over the competitor.
-4.79%
Negative yoy CapEx while BTE is 15.28%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while BTE stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while BTE is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-113.63%
Both yoy lines negative, with BTE at -133.50%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-32.86%
Both yoy lines negative, with BTE at -5.88%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-79.29%
Negative yoy issuance while BTE is 24.12%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
95.12%
Buyback growth of 95.12% while BTE is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.